Shionogi, Inc.

News

01/25/2012	Study data show Cuvposa® reduced chronic severe drooling in patients ages 3-16 years-old with neurologic conditions
12/07/2011	Shionogi & Co., LTD. and Shionogi Inc. announce a favorable decision in Fortamet® preliminary injunction proceedings
07/18/2011	Shionogi Inc. Signs Agreement to Expand its Portfolio with Acquisition of Nine Marketed Products From Victory Pharma, Inc.
05/09/2011	Shionogi Inc. Announces Publication of Data in Pediatrics Demonstrating Efficacy of Kapvay™ (clonidine hydrochloride) Extended Release Tablets as Add-On Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents